AIDS and Cancer Specimen Resource   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: San Francisco CA United States

Organization Overview

First Clinical Trial
2011
NCT01209325
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

AIDS and Cancer Specimen Resource

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anus Neoplasms (Phase 2)

Carcinoma in Situ (Phase 2)

Communicable Diseases (Phase 3)

Disease (Phase 2)

Infections (Phase 3)

Neoplasms (Phase 2)

Papillomavirus Infections (Phase 3)

Penile Neoplasms (Phase 2)

Precancerous Conditions (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Kaposi (Phase 2)

Squamous Intraepithelial Lesions of the Cervix (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 12